Related Experiment Video
Updated: Jul 22, 2026

The Nematode Caenorhabditis Elegans - A Versatile In Vivo Model to Study Host-microbe Interactions
Published on: October 18, 2017
The Role of HMGB1 in Invasive Candida albicans Infection
JiaoJiao Wang1, ChuanXin Wu2, YunYing Wang3
1Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, 400010, China.
Introduction:
High mobility group box 1 (HMGB1) is an important "late" inflammatory mediator in bacterial sepsis. Ethyl pyruvate (EP), an inhibitor of HMGB1, can prevent bacterial sepsis by decreasing HMGB1 levels. However, the role of HMGB1 in fungal sepsis is still unclear. Therefore, we investigated the role of HMGB1 and EP in invasive C. albicans infection.
Methods:
We measured serum HMGB1 levels in patients with sepsis with C. albicans infection and without fungal infection, and control subjects. We collected clinical indices to estimate correlations between HMGB1 levels and disease severity. Furthermore, we experimentally stimulated mice with C. albicans and C. albicans + EP. Then, we examined HMGB1 levels from serum and tissue, investigated serum levels of tumor necrosis factor α (TNF-α) and interleukin 6 (IL-6), determined pathological changes in tissues, and assessed mortality.
Results:
Serum HMGB1 levels in patients with severe sepsis with C. albicans infection were elevated. Increased HMGB1 levels were correlated with procalcitonin (PCT), C-reactive protein (CRP), 1,3-β-D-Glucan (BDG) and C. albicans sepsis severity. HMGB1 levels in serum and tissues were significantly increased within 7 days after mice were infected with C. albicans. The administration of EP inhibited HMGB1 levels, decreased tissue damage, increased survival rates and inhibited the release of TNF-α and IL-6.
Conclusions:
HMGB1 levels were significantly increased in invasive C. albicans infections. EP prevented C. albicans lethality by decreasing HMGB1 expression and release. HMGB1 may provide an effective diagnostic and therapeutic target for invasive C. albicans infections.
Insights
High mobility group box 1 (HMGB1) is elevated in invasive Candida albicans infections. Ethyl pyruvate (EP) reduces HMGB1, preventing fungal sepsis lethality and offering a potential therapeutic target.
Area of Science:
- Immunology
- Infectious Diseases
- Pharmacology
Background:
- High mobility group box 1 (HMGB1) is a known inflammatory mediator in bacterial sepsis.
- The role of HMGB1 in fungal sepsis, specifically invasive Candida albicans infections, remains largely uncharacterized.
- Ethyl pyruvate (EP) is an established inhibitor of HMGB1, demonstrating efficacy in bacterial sepsis models.
Purpose of the Study:
- To investigate the role of HMGB1 in invasive Candida albicans infections.
- To evaluate the therapeutic potential of Ethyl pyruvate (EP) in a model of fungal sepsis.
Main Methods:
- Serum HMGB1 levels were measured in patients with C. albicans sepsis and controls.
- Correlations between HMGB1 levels and clinical severity markers (PCT, CRP, BDG) were assessed.
- Mice were infected with C. albicans and treated with EP, monitoring HMGB1, inflammatory cytokines (TNF-α, IL-6), tissue damage, and mortality.
Main Results:
- Elevated serum HMGB1 levels were observed in patients with severe C. albicans sepsis, correlating with disease severity markers.
- HMGB1 levels significantly increased in mice following C. albicans infection.
- EP administration reduced HMGB1 levels, mitigated tissue damage, decreased pro-inflammatory cytokine release, and improved survival rates.
Conclusions:
- HMGB1 is significantly upregulated during invasive C. albicans infections.
- Ethyl pyruvate demonstrates a protective effect against C. albicans-induced lethality by inhibiting HMGB1.
- HMGB1 presents a promising diagnostic and therapeutic target for invasive fungal infections.
Related Concept Videos
Cytomegalovirus Disease
Cryptococcal Meningitis
Candidiasis

